Efficient in vitro and in vivo gene regulation of a retrovirally delivered pro-apoptotic factor under the control of the Drosophila HSP70 promoter
- 1 April 2001
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 8 (8) , 600-607
- https://doi.org/10.1038/sj.gt.3301441
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 25 references indexed in Scilit:
- Gene silencing as a threat to the success of gene therapyJournal of Clinical Investigation, 2000
- Variegation of retroviral vector gene expression in myeloid cellsGene Therapy, 2000
- Temporal, spatial, and cell type–specific control of Cre-mediated DNA recombination in transgenic miceNature Biotechnology, 1999
- Promoter-activated expression of nerve growth factor for treatment of neurodegenerative diseasesGene Therapy, 1999
- Induction of GADD45 and JNK/SAPK-Dependent Apoptosis following Inducible Expression of BRCA1Published by Elsevier ,1999
- Tetracycline-regulatable factors with distinct dimerization domains allow reversible growth inhibition by p16Nature Genetics, 1998
- Reversible immortalization of mammalian cells mediated by retroviral transfer and site-specific recombination.Proceedings of the National Academy of Sciences, 1996
- Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter.Proceedings of the National Academy of Sciences, 1994
- Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells.Proceedings of the National Academy of Sciences, 1986
- Sequence organization of two recombinant plasmids containing genes for the major heat shock-induced protein of D. melanogasterCell, 1979